A detailed history of Brown Shipley& CO LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Brown Shipley& CO LTD holds 104 shares of MRNA stock, worth $3,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Holding current value
$3,511
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$36.85 - $63.93 $3,832 - $6,648
104 New
104 $4.32 Million
Q3 2023

Nov 21, 2023

BUY
$96.41 - $126.61 $9,158 - $12,027
95 New
95 $9.81 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $6.93 Million - $9.39 Million
58,512 New
58,512 $18.9 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Brown Shipley& CO LTD Portfolio

Follow Brown Shipley& CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Shipley& CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brown Shipley& CO LTD with notifications on news.